PYREXIA is the #5 most commonly reported adverse reaction for MYCOPHENOLATE MOFETIL, manufactured by Genentech, Inc.. There are 5,434 FDA adverse event reports linking MYCOPHENOLATE MOFETIL to PYREXIA. This represents approximately 2.1% of all 256,184 adverse event reports for this drug.
MYCOPHENOLATE MOFETIL has an overall safety score of 85 out of 100. Patients taking MYCOPHENOLATE MOFETIL who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA5,434 of 256,184 reports
PYREXIA is a less commonly reported adverse event for MYCOPHENOLATE MOFETIL, but still significant enough to appear in the safety profile.
Other Side Effects of MYCOPHENOLATE MOFETIL
In addition to pyrexia, the following adverse reactions have been reported for MYCOPHENOLATE MOFETIL:
PYREXIA has been reported as an adverse event in 5,434 FDA reports for MYCOPHENOLATE MOFETIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with MYCOPHENOLATE MOFETIL?
PYREXIA accounts for approximately 2.1% of all adverse event reports for MYCOPHENOLATE MOFETIL, making it a notable side effect.
What should I do if I experience PYREXIA while taking MYCOPHENOLATE MOFETIL?
If you experience pyrexia while taking MYCOPHENOLATE MOFETIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.